NeuroPace (NASDAQ:NPCE) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.24) by 12.5 percent. This is a 34.38 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $22.52 million which beat the analyst consensus estimate of $21.85 million by 3.10 percent. This is a 24.28 percent increase over sales of $18.12 million the same period last year.